Skip to content
PBM roundup: the top 6 actions to watch
It is already shaping up to be a tough year for Pharmacy Benefit Managers (PBMs) as federal regulators and politicians work to shed light […]
PBM roundup: the top 6 actions to watch Read More »
Health
As biotech market seeks rebound, economic and political environments are key
If you are a regular reader of Bio.News, you likely know that the past two years have been difficult for the biotech market. Investor
As biotech market seeks rebound, economic and political environments are key Read More »
I am BIO Podcast: Space station launches low-gravity biotech advances
“Biotech in space” may sound like the title of an old sci-fi movie but the real-life partnership offers tantalizing potential, an I am BIO
I am BIO Podcast: Space station launches low-gravity biotech advances Read More »
Supreme Court says mifepristone can stay – for now
After weeks of tension, the Supreme Court decided mifepristone can stay… for now. On the evening of April 21, the Supreme Court ruled the
Supreme Court says mifepristone can stay – for now Read More »
U.S. surge in STIs threatens to converge with antimicrobial resistance
With an upsurge in sexually transmitted infections (STIs) as well as the threat of antimicrobial resistance (AMR), the U.S. must take essential action to
U.S. surge in STIs threatens to converge with antimicrobial resistance Read More »
5 new discoveries at the American Association for Cancer Research annual meeting
The American Association for Cancer Research (AACR) hosted its 114th annual meeting in Florida in April. Scientists, medical professionals, and many others came together
5 new discoveries at the American Association for Cancer Research annual meeting Read More »
We’re losing the fight against superbugs. The time to act is now.
Americans are rightly anxious about the increasing prevalence of serious and deadly infections associated with drug-resistant pathogens – also known as antimicrobial resistance (AMR).
We’re losing the fight against superbugs. The time to act is now. Read More »
The week in mifepristone and understanding the deeper impacts
With the Texas ruling against the product mifepristone on April 7, the biotech industry came together to both denounce the ruling and help the
The week in mifepristone and understanding the deeper impacts Read More »
Why pediatric sepsis is on the rise – and what we can do about it
Concerns over sepsis, a life-threatening reaction to infections, are on the rise. And growing antimicrobial resistance (AMR) is making the condition harder to treat.
Why pediatric sepsis is on the rise – and what we can do about it Read More »
House Energy & Commerce subcommittee spotlights ‘unfair’ PBM practices
On April 18, the House Energy and Commerce Innovation, Data, and Commerce Subcommittee held a hearing on the Federal Trade Commission’s (FTC) budget for
House Energy & Commerce subcommittee spotlights ‘unfair’ PBM practices Read More »